Public Documents

Home / Public Documents
  • Deliverable 2.1 – Aptamer-mediated guidance of CaP (M12) – PDF
  • Deliverable 2.3 – EMD-mediated guidance of FeCaP (M12) – PDF
  • Deliverable 3.1 – In vitro assessment of nanoparticle behavior at/across the pulmonary barrier (M12) – PDF
  • Deliverable 3.3 – In vivo assessment of the studied nanoparticles using different imaging modalities (M12) – PDF
  • Deliverable 4.1 – Distribution of electromagnetic fields in the target area due to the drug targeting systems – PDF
  • Deliverable 4.4 – Extended model, describing the relationship between FeCaPs and deposition site when exposed to an external magnetic field (M12) – PDF
  • Deliverable 10.1 – Visual identity kit (M12) – PDF
  • Deliverable 10.4 – Web portal, Social Media –  PDF
  • Deliverable 10.10 – Press Release (M3) –  PDF
  • Deliverable 10.11 – Press Release (M12) – PDF
  • Deliverable 10.14 – Summary of annual workshops and networking events building communities (M12) – PDF